VZ-Vax (Live Attenuated Varicella Virus)

Live Attenuated Varicella Virus is a live attenuated vaccine formulated to provide active immunization against varicella (chickenpox) caused by the Varicella-Zoster virus (VZV). The vaccine contains a weakened strain of the virus that safely stimulates the immune system to develop long-lasting immunity without causing the disease itself.

It helps reduce the incidence and severity of chickenpox infections and prevents complications such as bacterial superinfection, pneumonia, and encephalitis. 

Main Uses:

• Active immunization for the prevention of varicella (chickenpox) in healthy individuals aged 12 months and older
• Recommended for susceptible adolescents and adults without prior varicella infection or vaccination
• Can be administered as post-exposure prophylaxis within a few days of exposure to Varicella-Zoster virus

Contraindications:

• Hypersensitivity to any vaccine component, including neomycin or gelatin
• Immunocompromised patients (e.g., those with leukemia, lymphoma, HIV infection, or on immunosuppressive therapy)
• Pregnancy (avoid conception for at least 1 month post-vaccination)
• Active febrile illness or severe acute infection
• History of severe allergic reaction to previous varicella-containing vaccines

Dosage: The dosage of this medicine depends on the prescription and instruction given by the doctor.

Precautions: Do not take this medicine without any medical consultation with your doctor.